{"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}],"groups":[{"description":"Participants undergo short course vaginal cuff brachytherapy for 2 fractions with 1 week apart.","id":"BG000","title":"Experimental: Short Course Vaginal Cuff Brachytherapy"},{"description":"Participants undergo standard of care vaginal cuff brachytherapy for 3-5 fractions over no more than 3 weeks.","id":"BG001","title":"Control: Standard of Care Vaginal Cuff Brachytherapy"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"53"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"55"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.25","value":"65.31"},{"groupId":"BG001","spread":"9.68","value":"63.65"},{"groupId":"BG002","spread":"9.95","value":"64.48"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"40","upperLimit":"84","value":"66.5"},{"groupId":"BG001","lowerLimit":"30","upperLimit":"87","value":"63.5"},{"groupId":"BG002","lowerLimit":"30","upperLimit":"87","value":"65"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"11"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"94"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"10"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"86"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"9"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"108"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"21.5","value":"72.28"},{"groupId":"BG001","spread":"21.74","value":"67.88"},{"groupId":"BG002","spread":"21.26","value":"70.17"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"100"}],"units":"Participants"}]}],"description":"The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-30 (QLQ-30) is used to evaluate quality of life in cancer patients. The quality of life score ranges from 0-100, with higher scores indicating better quality of life.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"The primary outcome related to this baseline measure requires participants to have completed both the baseline and Month 1 assessments to be included. Participants without both were excluded in this baseline measure. Five control arm participants did not complete the Month 1 questionnaire. One control arm participant did not complete the baseline questionnaire. Two experimental arm participants did not complete the Month 1 questionnaire.","title":"Baseline EORTC Quality of Life Score","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"26.24","value":"10.46"},{"groupId":"BG001","spread":"28.35","value":"16.67"},{"groupId":"BG002","spread":"27.32","value":"13.47"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"99"}],"units":"Participants"}]}],"description":"The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Endometrial-24 (QLQ-EN24) was used to evaluate quality of life in cancer patients with endometrial cancers. From this assessment, one question was selected as an indicator for this outcome, which measured whether participants felt less feminine as a result of their disease or treatment. The score ranges from 0-100, with higher scores indicating feeling less feminine.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"The secondary outcome related to this baseline measure requires participants to have completed both baseline and Month 1 questionnaires to be included. Participants who did not complete both were excluded. Five control arm participants did not complete the Month 1 questionnaire. One control arm participant did not complete the baseline questionnaire. Three experimental arm participants did not complete the Month 1 questionnaire.","title":"Baseline EORTC Symptom Score","unitOfMeasure":"score on a scale"}]}